Physician profile
John B Bitner
NPI 1336129543
$176,585.93
in general payments reported to CMS, 2019-2025
9 companies · $5,495 in 2025
The $5,495 reported for 2025 was more than what 96% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.09 · 2020: $66.05 · 2021: $133K · 2022: $21K · 2023: $10K · 2024: $7,025 · 2025: $5,495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Food and Beverage: $476 · Long Term Medical Supply Or Device Loan: $423 · Education: $16.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,985.65 |
| Food and Beverage | $476.49 |
| Long Term Medical Supply Or Device Loan | $422.62 |
| Education | $16.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $156,137.70 | 2019-2023 | |
| Abbvie INC. | $19,646.26 | 2023-2025 | Botox, Kybella |
| Integra Lifesciences Corporation | $422.62 | 2025 | Durasorb Monofilament Mesh |
| Galderma Laboratories, L.P. | $151.34 | 2019-2025 | |
| Revance Therapeutics, INC. | $73.61 | 2024 | Daxxify |
| Merz North America, INC. | $56.52 | 2022-2025 | Xeomin |
| Apyx Medical Corporation | $52.43 | 2019 | |
| Boston Scientific Corporation | $26.56 | 2024 | Spectra Wavewriter |
| Tela Bio, INC. | $18.89 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bitner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.